RUNX1 and leukemia: On one hand, RUNX1 is part of the AML1-ETO fusion protein, which can directly inhibit the transcription of tumor suppressor genes dependent on RUNX1, disrupting normal hematopoietic cell differentiation and promoting leukemia development.